Cadrenal Therapeutics (NASDAQ: CVKD) outlines CMO Ferguson's exit deal
Cadrenal Therapeutics (NASDAQ: CVKD) has detailed the terms of its Chief Medical Officer, Dr. James J. Ferguson III's, departure. Dr. Ferguson's resignation is effective July 31, 2026, and the separation agreement includes salary payments through this date, reimbursement of approved business expenses, and company-paid …